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1. Introduction
  Chikungunya virus (CHIKV) is a mosquito-transmitted 
alphavirus that belongs to the Togaviridae family[1]. It 
causes chikungunya fever (CHIK fever), a febrile illness 
associated with severe arthralgia and rash[2-5]. Chikungunya 
is a Makonde word (Bantu language) meaning ‘The one 
which bends up’ referring to the posture of the affected 
patient acquired due to excruciating pain in the joints[6].
  The CHIKV is a small (about 60-70 nm-diameter), 
spherical, enveloped, positive-strand RNA virus[7- 9].
  Its genome is about 12 kb long and is capped in 5′ and has 
a polyA tail in the 3′ end. The genome structure includes 
two open reading frames (ORFs) that encodes for two 
polyproteins (non-structural polyprotein and structural 
polyprotein), which can be cleaved respectively into four 
non-structural proteins (nsP1, nsP2, nsP3, nsP4) and five 
structural proteins (C, E3, E2, 6K, E1) by viral and cellular 
proteases[10]. 
  Chikungunya virus is transmitted by culicine mosquitoes  and 
can alternatively affects vertebrates and arthropods[11,12]. 
The arthropods remain infected throughout all its life. Its 
transmission to humans is mainly through Aedes species 
mosquitoes[13]. Aedes aegypti, Aedes albopictus and Aedes 
polynesiensis are commonly involved in the transmission 
although Culex has also been reported for the transmission 
in some cases[1,13,14].
  African CHIKV circulates primarily in a sylvatic/
enzootic cycle, transmitted by arboreal primatophilic 
Aedes mosquitoes (eg., Aedes furcifer and Aedes africanus) 
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and probably relies on nonhuman primates as reservoir 
hosts[13,15]. 
  A recent Indian study reported transmission of 
chikungunya virus by Anopheles stephensi too[16]. The Indian 
Ocean outbreak is caused by transmission by Aedes only[1]. 
The common reservoirs for chikungunya virus are monkeys 
and other vertebrates. The role of cattles and rodents has 
also been reported in the transmission of the virus[13]. 
  The CHIKV usually shows a periodicity with occurrence 
of disease in the community with latency intervals of 
3-4 years, probably due to its cycle in monkeys[11,13]. 
Following transmission, CHIKV replicates in the skin, and 
disseminates to the liver, muscle, joints, lymphoid tissue 
(lymph nodes and spleen) and brain, presumably through the 
blood (Figure 1)[17-20]. 
Figure 1. Virus dissemination and target organs.  
CHIKV spreads rapidly in the body after initial infection. Following 
inoculation with CHIKV through a mosquito bite, the virus directly 
enters the subcutaneous capillaries, with some viruses infecting 
susceptible cells in the skin, such as macrophages or fibroblasts and 
endothelial cells. Local viral replication seems to be minor and limited 
in time, with the locally produced virus probably being transported 
to secondary lymphoid organs close to the site of inoculation. Virus 
dissemination through the blood and pathological events associated. 
True arthritis remains a rare event (from 2% to 10%).  (Dupuis-
Maguiraga et al, 2012).
 
  The pathological events associated with tissue infection 
are mostly subclinical in the liver (hepatocyte apoptosis) and 
lymphoid organs (adenopathy), whereas in the muscles and 
joints are associated with very strong pain, with some of the 
patients presenting arthritis (Figure 1)[19,20]. 
  Symptoms of CHIKV infection include high fever, 
rigors, headache, photophobia and a petechial rash or 
maculopapular rash. In addition, most infected individuals 
complain of severe joint pain that is often incapacitating and 
a painful inguinal lymphadenopathy was also reported in a 
case study of a 28-year-old woman[21-24]. 
  ‘Silent’ infections do occur but are rare, being observed in 
around 15% of infected individuals[25]. 
  The acute phase of CHIKV infection typically lasts from 
a few days to a couple of weeks. However, arthralgia and/
or myalgia may persist for weeks, months, or even years. 
Some patients go on to develop a genuine, chronic arthritic 
syndrome[26,27].
  Typically, joint damage fluctuates over time, but always 
affects the same parts of the body, mostly the extremities 
(hands, ankles, knuckles)[20,28-30]. The mortality rate is low 
(0.4%), but is higher in babies less than 1 year old (2.8%) and 
increases in the elderly with concurrent diseases[29].
  There is no specific treatment for CHIK and no vaccine is 
currently available. The illness is usually self-limiting and 
resolves with time. Supportive care with rest is indicated 
during the acute joint symptoms[31]. Infective persons 
should be protected from further mosquito exposure (staying 
indoors and/or under mosquito net during the first few days 
of illness) so that they cannot contribute to the transmission 
cycle[32]. 
  Laboratory diagnosis relies upon the detection of the virus 
on early samples and/or specific anti-CHIKV IgM and IgG on 
blood samples[33]. Commercial kits are available, sometimes 
with excellent sensitivity and specificity[34] For example 
the commercial Chikungunya virus real-time reverse 
transcription-PCR (RT-PCR) kit, by Panning et al, 2009, was 
100% sensitive and specific in comparison to a published 
real-time RT-PCR[34]. This commercial CHIKV kit may 
assist laboratories in affected regions and serve the needs of 
outpatient travel medicine clinics worldwide. The capability 
of quantifying virus RNA concentrations may facilitate 
the monitoring of disease progression and the assessment 
of risks of transmission in the nosocomial situation[35]. In 
addition, this kit may help in regions where CHIKV vectors 
Aedes aegypti and Aedes albopictus are subject to virus 
surveillance[34]. 
  Anti-CHIKV antibodies can be detected in patients shortly 
after symptom onset, usually after 5 days for IgM and only a 
few days later for IgG. Commercial enzyme immunoassays 
and immunofluorescence assays are available[36]. 
  Possible problems in the interpretation of the serological 
results could be a) possible false negativity due to CHIKV 
induced mixed cryoglobulinemia[37], b) cross-reactivity 
with viruses of the Semliki Forest serocomplex requiring 
seroneutralization, and c) long-term persistence of anti-
CHIKV IgM months after disease onset[33]. To demonstrate 
a recent CHIKV infection in most cases is sufficient a 
synchronous testing of a sample from the acute stage and a 
sample collected at least 3 weeks later[33].
  For diagnosis, monitoring, detection and genotyping of 
CHIKV, conventional reverse transcription-polymerase 
chain reaction (RT-PCR) methods have been used. 
Regarding the detection of CHIKV-RNA, it can be detected 
in plasma samples within the first week after symptom onset, 
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commonly with extremely high levels of viremia[38].
  Real-time quantitative RT-PCR to detect and quantify the 
CHIKV was also developed[39]. This method is sensitive and 
specific and detects a wide range of CHIKV concentrations.
  More recently, a positive- and negative-strand quantitative 
Real-Time Polymerase Chain Reaction (qRT-PCR) assays 
for CHIKV nsP3 was designed for diagnosis and studying 
virus replication[40].  This positive- and negative-strand 
qRT-PCR assays had limits of quantification of 1 and 3 log10 
RNA copies/reaction, respectively. Compared to a published 
E1 diagnostic assay using 30 laboratory-confirmed clinical 
samples, the positive-strand nsP3 qRT-PCR assay had 
higher R2 and efficiency and detected more positive 
samples[40].
  A SYBR Green I based quantitative RT-PCR assay was 
also recently developed[41]. This assay was found to be 10-
fold more sensitive than conventional RT-PCR and no 
cross reactivity was observed with related alphaviruses and 
flaviviruses. 
  A novel molecular diagnostic platform that ensures a 
rapid and cost-effective one-step RT-PCR assay, with high 
sensitivity and specificity, for the early detection of the 
Chikungunya virus (CHIKV) was also developed[42]. It uses 
2,7-diamino-1,8-naphthyridine derivative (DANP)-labeled 
cytosine-bulge hairpin primers to amplify the nsP2 region 
of the CHIKV genome, followed by measurement of the 
fluorescence emitted from DANP-primer complexes after 
PCRs. 
  The detection limit of othis assay was 0.01 plaque-forming 
units per reaction of CHIKV. An advantage of this assay 
could be represented by the fact that the HP-nsP2 primers 
were highly specific in detecting CHIKV, without any cross-
reactivity with the panel of RNA viruses validated in this 
study. The feasibility of the DANP-coupled hairpin RT-
PCR for clinical diagnosis was evaluated[42] using clinical 
serum samples from CHIKV-infected patients, and the 
specificity and sensitivity were 100% (95% CI, 80.0% to 100%) 
and 95.5% (95% CI, 75.1% to 99.8%), respectively. This Novel 
DANP-Coupled Hairpin RT-PCR assay should be used as a 
potential clinical molecular diagnostic assay for CHIKV in 
acute-phase patient serum samples.
2. Epidemiology and spread of CHIKV
  Chikungunya fever was first reported in 1952 from 
Makonde plateaus, along the borders between Tanzania and 
Mozambique[6,43]. Chikungunya virus was first isolated by 
Ross in 1953 from the serum of a febrile human during an 
epidemic in Newala district of Tanzania[44]. 
  The virus probably originated in Africa[1,12,45] where it 
maintained in ‘sylvatic cycle’ involving wild primates and 
forest dwelling mosquitoes[11,12,14,46].
  Chikungunya was introduced subsequently in Asia where 
it has been transmitted from human to human mainly by
Aedes aegypti and, to a lesser extent by Aedes albopictus 
through an urban transmission cycle[45,46].
  Since Tanzania outbreak in 1952, chikungunya virus 
caused outbreaks (emerging and re-emerging) between the 
1960s and 1990s in East Africa (Uganda)[1,47], in Zimbabwe[48], 
in West Africa (Senegal)[13,49], and in Central Africa (Central 
African Republic, Democratic Republic of the Congo and 
Cameroon)[11,46,48,50,51].
  Chikungunya virus has also been reported from Portugal 
and Guinea[12]. Philippines, Malaysia, Mayotte and Reunion 
Island are commonly affected in Asia[52].
  The chronological order of the documented outbreaks of 
CHIKV was described by Powers and Logue[54].
  The first documented Asian outbreak was in 1958[46,54-56]. 
The outbreaks in Africa and Asia, were unpredictable, with 
interval of 7 to 20 years between two consecutive epidemics.
  In India there was a confirmed history of outbreaks during 
1963-64 in Kolkata[57] (earlier known as Calcutta) and 1965 
in Chennai (earlier known as Madras)[58,59]. The entry of 
chikungunya virus in India was unknown although Calcutta 
Sea and air roots are believed to be the probable entry 
points[60]. 
  Among the numerous large cities in South East Asia 
also Bangkok has been identified as a particularly active 
site of transmission and disease[49,61-63]. Outbreaks have 
been documented in Cambodia, Vietnam, Laos, Myanmar 
too[55]. In 2004, a large epidemic of CHIKV, sustained by 
the circulation of the East-Central-South African (ECSA) 
genotype, started on the coast of Kenya, followed in 2005 by 
sequential outbreaks on the Comoros, La Reunion, and other 
islands in the southwest Indian Ocean. On Reunion island 
alone there were approximately 266 000 cases (34% of the 
total island population)[5,64,65].
  Then, an epidemic due to the same strain ravaged the 
Indian subcontinent in 2005- 2006, causing more than one 
and half million cases[66]. 
  Interestingly, during the epidemic in La Reunion, the virus 
apparently mutated. The A226V mutation allowed the virus to 
better adapt to Aedes albopictus, the only competent vector 
present on the island[1]. Viral strains with the same mutation 
were also identified in India and caused an outbreak in 
North-eastern Italy[67,68]. In particular the outbreak reported 
in Emilia- Romagna Region (North-eastern Italy) in the 
summer of 2007 represented the first epidemic reported in a 
temperate area, probably related to the a high concentration 
of  Aedes albopictus that affected this area[69].
  Other cases were reported in Europe (UK, Belgium, 
Germany, Czech Republic, Norway, Spain and France), 
Hong Kong, Canada, Taiwan, Sri Lanka and the USA; these 
cases were directly associated with the return of travellers 
from India and affected islands of the Indian Ocean[53,70].
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3. Phylogeny
  Primarily phylogenetic analysis divided the CHIK virus 
isolates into three distinct genotypes based on geographical 
origins. The first clade consisted of the isolates from Senegal 
and Nigeria, forming the West Africa genotype (WAf). 
The remaining isolates formed two clades: one contained 
strains from central and eastern Africa (Central/East 
African genotype), while the other contained solely Asian 
isolates[71]. Genetic studies by Lanciotti et al[47] as well as 
the phylogenetic analyses presented by Powers[71] clearly 
demonstrate that ONN and CHIK viruses are genetically 
distinct. The paraphyletic grouping of the African CHIK 
viruses supports the historical evidence that the virus was 
introduced into Asia from Africa[45,71]. 
  A recent study[72] investigated the CHIKV genotype  in 
patients in Cambodia and analyzed the phylogenetic origin 
of the strains.  The phylogenetic analysis performed by 
the authors showed that CHIKV was composed by three 
genotypes: West Africa, Asia and East/Central/South African 
(ECSA) (Figure 2). The viruses from Cambodia clustered with 
those isolated during the Indian Ocean outbreak and within 
the ECSA phylogenetic group (Figure 2). 
Figure 2. Phylogenetic tree based on the whole genome of CHIKV. 
Viruses were identified by using the GenBank accession number, 
country code, and year of isolation. Boldface indicates strains from 
Cambodia; circles indicate isolates from Preah Vihear Province; 
triangles indicate strains from Battambang Province. All 8 strains 
from Cambodia carried the A226V mutation. Numbers represent the 
bootstrap support obtained for respective branches (>70). The tree was 
rooted by o’nyongnyong virus (GenBank accession no. AF079456, 
UGA96-ONNV). ECSA, East Central South African genotype. Scale 
bars indicate nucleotide substitutions per site (Duong et al, 2012).
 
  Another recent study[15] showed that the CHIKV 
phylogenetic trees included three distinct CHIKV clades, 
namely, ECSA (East/Central/South African), West Africa, 
and Asian, with the recent Indian Ocean basin outbreak 
forming a monophyletic lineage descendant from the ECSA 
clade. The divergence of each distinct lineage reflected, to 
some extent, the path of global transmission and occasional 
outbreaks. The authors showed that, excluding the 5’ and 
3’ 20 nucleotides (nt) that were not sequenced, the genome 
length varied among and within geographic lineages, with 
those in the ECSA lineage being shorter (11 557 to 11 789 nt) 
than the WAf (11 843 to 11 881 nt) and Asian (11 777 to 11 999 
nt) strains. 
  The authors[15] also found nucleotide differences in all 
genes, and the most variable genome regions included 
the 5’ and 3’ UTRs, as well as the 26S junction region. 
They observed that the ORFs were highly conserved, with 
occasional indels observed in high-passage strains. Because 
of the highly divergent UTRs made accurate alignments 
impossible the authors excluded the UTRs from the 
phylogenetic analyses and found poly(A) insertions in the 3’ 
UTRs of two ECSA strains  in addition to the Ross strain[73]. 
The insertion in the Senegal bat strain, which is located in 
the ECSA group, is in a different location from the other two, 
suggesting their independent generation. 
  A  maximum parsimony, neighbour joining and maximum 
likelihood analysis was conducted on partial E1 gene 
sequences[71]; both the maximum-likelihood (ML) method 
and the Metropolis-coupled Markov Chain Monte Carlo 
(MCMCMC) method  was peformed by Volk[15], they also 
estimated evolutionary rates and times to the most recent 
common ancestors on CHIKV genomic sequences. A recent 
phylogenetic study[45]  analyzed  CHIKV data set of partial E1 
nucleotide sequences and estimated the evolutionary rates, 
the time-scaled phylogeny reconstruction and Bayesian 
phylogeography (Figure 3). Volk[15], showed that the  overall 
nucleotide substitution rate was 4.33伊10-4 nucleotide 
substitutions per site per year (subs/nt/year) and that the 
rates estimated for each lineage exhibited considerable 
variation, with those for the epidemic lineages significantly 
higher than those estimated for the enzootic lineages. 
The authors showed that the Asian lineage exhibited a 
significantly higher substitution rate (i.e., non- overlapping 
HPD values) (4.16伊10-4 subs/nt/yr; 95% HPD: 3.26伊10-4  to 
5.02伊10-4 subs/nt/year) than the WAf (2.39伊10-4 subs/nt/year; 
95% HPD: 1.98伊10-4  to 2.84伊10-4 subs/nt/year) and ECSA 
lineages (2.30伊10-4 subs/nt/year; 95% HPD: 1.37伊10-4  to 3.24
伊10-4 subs/nt/year). The Indian Ocean epidemic lineage 
yielded an even higher rate estimate (8.46伊10-4 subs/nt/year; 
95% HPD: 5.81伊10-4 to 1.09伊10-3 subs/nt/year).
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Figure 3. Significant non-zero rates for CHIKV E1 sequences. 
Only rates supported by a BF of > 3 were considered significant, and 
highlighted with arrows. In the Figure are showed the probable gene 
flows from the Origin (Kenya) to the other countries (Lo Presti et al, 
2012).
  CHIKV E1 evolutionary rate reported by a phylogeographic 
study[45] for the whole dataset was 1.4伊10-3 substitution/site/
year (95% HPD 6.4伊10-4-2.5伊10-3). The assessment of the 
evolutionary rate of the subset including only the strains 
involved in the recent Indian Ocean epidemic, gave an 
estimation of 2.2伊10-3 (95% HPD 9.6伊10-4-3.8伊10-3). The 
authors reconstructed the geographic spread of CHIKV 
during the last epidemic wave, which showed an eastward 
path from Africa to Indian Ocean Island to India, and from 
there to other South East Asian countries (Figure 3) [45].
  Phylogenetic studies also showed that the Indian Ocean 
and the Indian subcontinent epidemics were caused by 
two different introductions of distinct strains of the ECSA 
genotype of CHIKV[45,74,75].
  A single E1-A226V mutation was sufficient to dramatically 
increase the ability of different strains of CHIKV to infect 
Ae. albopictus mosquitoes and this substitution required 
no additional adaptive mutations to gain intermolecular 
compatibility[76]. 
  A study of strains obtained from the Democratic Republic of 
Congo during an urban outbreak in 1999-2000 demonstrated 
the close genetic relationship of these isolates with other 
strains from Central Africa[51] .
  Since the major CHIK outbreak began in 2004, additional 
phylogenetic studies have been performed, most focusing on 
recent isolates[45] .
  The MRCA for the recent epidemic which ravaged Indian 
Ocean islands and the Indian subcontinent in the years 
2004-2007 was found to date in 2002[45], confirming the 
findings of a previous study[71]. Differently, a mathematical 
model by Cherian[77]  estimated the progenitor of the 2005-
2007 viruses to exist up to 9 years before. This appeared 
to be corroborated by the presence of a strain in India in 
2000 that beared 99% identity with an Ugandan strain of 
1982 and a high similarity with strains isolated during the 
recent CHIKV epidemic[74,78]. However, other studies did not 
support this finding that has been hypothesized to be the 
result of contamination[15] .
  Asian lineage dated about 1952 and exhibited similar 
spread patterns of the recent Indian Ocean outbreak lineage, 
with successive epidemics detected along an eastward 
path[15]. Asian group splitted into two clades: an Indian 
lineage, which likely went extinct, and a south east lineage. 
The old Asia genotype has not been identified during the 
last epidemic in India. This was consistent with lack of 
sustainability of the human-mosquito cycle at a local scale 
in the absence of continued importation[15,79] .
  Outbreaks of CHIKV fever in Asia had not been necessarily 
associated with outbreaks in Africa, which suggested an 
independent evolution of an African ancestor of CHIKV in 
Asia[45,80]. A new study on the phylogeny of Aedes albopictus 
and Aedes aegypti showed that Aedes albopictus probably 
spread in different times to the Indian Ocean islands starting 
from Madagascar, where these species where limited at the 
end of the XIX century[81].
  On the contrary, Aedes albopictus was only recently 
introduced in Comores. These differences in the ecology 
of Aedes albopictus and Aedes aegypti could explain the 
simultaneous circulation of a wild type virus in the Comores 
and a mutated strain in La Reunion[81] .
4. Conclusion
  Phylogenetic tools are important to reconstruct the 
geographic spread of CHIKV during the epidemics wave, 
because they can highlight a possible different way of virus 
diffusion i.e. the eastward path from Africa to Indian Ocean 
island to India, and from there to other South East Asian 
countries as also recently demonstrated[45] .
  Some CHIKV cases outside tropical countries (ie. Italy) were 
directly associated with the return of travellers from India 
and from affected areas of the Indian Ocean and the major 
determinant of the outbreaks  was the high density of the 
vector  at the time of arrival of the index case. 
  Since the transmission of CHIKV is mediated by vectors, 
an issue to be considered and that has a fundamental role 
is the re-introduction and colonization of Aedes species in 
new areas and the problem of the vector control for disease 
containement.
  The mosquito species Aedes albopictus originated in 
Southeast Asia, but has spread during the last 30-40 years 
to North, Central and Southern America, parts of Africa, 
northern Australia and several countries in Europe. The
Aedes albopictus can colonise new geographical locations 
due to its ability to adapt to different climates[http://www.
ecdc.europa.eu/en/healthtopics/vectors/mosquitoes/Pages/
aedes-albopictus.aspx].  
  Instead Aedes aegypti is an important invasive mosquito 
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species that could potentially have an impact on European 
public health. It is found throughout tropical and subtropical 
regions of America, Africa and Asia, as well as southeastern 
US, Indian Ocean Islands and northern Australia. This 
species was established in Europe in the beginning of 
the 20th century and was also recently re-introduced in 
Europe[http://www.ecdc.europa.eu/en/healthtopics/vectors/
mosquitoes/Pages/aedes-aegypti.aspx]. 
  Possible measures for vector control could be the use of 
fast-acting insecticides (synergised pyrethrins) for 3 days 
consecutively, to apply with a truck-mounted atomiser 
in public spaces and a backpack mist blower in private 
spaces. Antilarval measures using formulations of insect 
growth regulators. House-to-house interventions to 
eliminate breeding places, and to encourage community 
participation[67]. The occurrence of outbreaks of CHIKV 
infection in countries with a temperate climate highlighted 
that clinical and diagnostic capacities have to be developed 
where these vectors of exotic diseases already circulate.
  The good management of patients with acute CHIKV 
infection is essential for public health in susceptible areas 
with current Aedes spp activity. Chikungunya fever is 
diagnosed based on symptoms, physical findings (e.g., joint 
swelling), laboratory testing, and the possibility of exposure 
to infected mosquitoes (http://www.cdc.gov/chikungunya/).  
  The early diagnosis of CHIKV infection remains difficult 
because the clinical picture of CHIKV infection is similar 
to that of other viral infections, which results in frequent 
diagnostic uncertainty[82]. In areas with current Aedes 
spp activity, most health authorities recommend prompt 
suspicion of imported or autochthonous cases, adequate 
use of diagnostic tools, isolation of suspect patients, 
rapid contact with the local health department, and 
sometimes mandatory case declaration. The final aim is 
to avoid epidemics spreading around the new cases[33]. In 
conclusion, the present review gave a critical appraisal of 
the epidemiology, clinics and phylogenesis of CHIKV and 
reinforces the need to monitor the geographic spread of 
CHIKV, and the vectors. 
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